| FDA Faulted in Heparin Case The FDA didn't pursue leads that might have identified culprits in China during the 2008 heparin crisis, a congressional investigation found. online.wsj.com |
Peregrine Pharmaceuticals: Good Long Term Potential VFC submits: It's been a while since I've mentioned Peregrine Pharmaceuticals (PPHM), but I thought that the highs of April and May were a better time to sell than accumulate, so I left it alone. The mini-run earlier this year was based on a flurry of Press Releases outlining encouraging results from the ongoing Phase II trials that were to be presented at ASCO. Now that the hype has died down a bit and the stock is back to trading for around three dollars, Peregrine Pharmaceuticals may be worth a look as a "Phase II accumulation" pick, with eyes towards the conclusion of the ongoing trials and the future potential of both Bavituximab and Cotara. Complete Story » seekingalpha.com |
DR. SCHOLL’S® FOOTMAPPING® - Video Revolutionary FootMapping® Technology provides customized comfort and support for people with tired, achy feet feedproxy.google.com |
Clarient to Present at Two Investor Conferences in September [PR Newswire] - Clarient, Inc. , a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the biopharmaceutical industry, today announced that the Company is scheduled to make investor presentations at two investor conferences in the month of September. us.rd.yahoo.com |
Artistry Crème LuXury - Video Creme LuXury Combats Intrinsic Causes of Skin Aging with Industry Leading Technology feedproxy.google.com |